
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
HDAC Inhibitors: Innovative Strategies for Their Design and Applications
Mateusz Daśko, Beatriz de Pascual‐Teresa, Irene Ortín, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 715-715
Open Access | Times Cited: 44
Mateusz Daśko, Beatriz de Pascual‐Teresa, Irene Ortín, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 715-715
Open Access | Times Cited: 44
Showing 26-50 of 44 citing articles:
Epigenetic meets metabolism: novel vulnerabilities to fight cancer
Domenica Scumaci, Qingfei Zheng
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Domenica Scumaci, Qingfei Zheng
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Optimization of Resveratrol Used as a Scaffold to Design Histone Deacetylase (HDAC-1 and HDAC-2) Inhibitors
Beatriz Silva Urias, Aline Renata Pavan, Gabriela Ribeiro Albuquerque, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 10, pp. 1260-1260
Open Access | Times Cited: 9
Beatriz Silva Urias, Aline Renata Pavan, Gabriela Ribeiro Albuquerque, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 10, pp. 1260-1260
Open Access | Times Cited: 9
Different Effects of Valproic Acid on SLC12A2, SLC12A5 and SLC5A8 Gene Expression in Pediatric Glioblastoma Cells as an Approach to Personalised Therapy
Eligija Damanskienė, Ingrida Balnytė, Angelija Valančiūtė, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 968-968
Open Access | Times Cited: 8
Eligija Damanskienė, Ingrida Balnytė, Angelija Valančiūtė, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 968-968
Open Access | Times Cited: 8
HDACs as an emerging target in endocrine tumors: a comprehensive review
E. Klieser, Bettina Neumayer, Pietro Di Fazio, et al.
Expert Review of Endocrinology & Metabolism (2023) Vol. 18, Iss. 2, pp. 143-154
Closed Access | Times Cited: 4
E. Klieser, Bettina Neumayer, Pietro Di Fazio, et al.
Expert Review of Endocrinology & Metabolism (2023) Vol. 18, Iss. 2, pp. 143-154
Closed Access | Times Cited: 4
Long non-coding RNA H19 enhances the pro-apoptotic activity of ITF2357 (a histone deacetylase inhibitor) in colorectal cancer cells
Chiara Zichittella, Marco Loria, Adriana Celesia, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Chiara Zichittella, Marco Loria, Adriana Celesia, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
HDAC/H3K27ac-mediated transcription of NDUFA3 exerts protective effects on high glucose-treated human nucleus pulposus cells through improving mitochondrial function
Cheng Zheng, Dongshuai Guo, Tong Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Cheng Zheng, Dongshuai Guo, Tong Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Identification of Potential Inhibitors of Histone Deacetylase 6 Through Virtual Screening and Molecular Dynamics Simulation Approach: Implications in Neurodegenerative Diseases
Anas Shamsi, Moyad Shahwan, Azna Zuberi, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1536-1536
Open Access | Times Cited: 1
Anas Shamsi, Moyad Shahwan, Azna Zuberi, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1536-1536
Open Access | Times Cited: 1
Antagonistic Pharmacological Interaction between Sirtuin Inhibitor Cambinol and Paclitaxel in Triple-Negative Breast Cancer Cell Lines: An Isobolographic Analysis
Anna Wawruszak, Jarogniew J. Łuszczki, Estera Okoń, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6458-6458
Open Access | Times Cited: 7
Anna Wawruszak, Jarogniew J. Łuszczki, Estera Okoń, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6458-6458
Open Access | Times Cited: 7
The Histone Deacetylase Inhibitor ITF2357 (Givinostat) Targets Oncogenic BRAF in Melanoma Cells and Promotes a Switch from Pro-Survival Autophagy to Apoptosis
Adriana Celesia, Antonietta Notaro, Marzia Franzò, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1994-1994
Open Access | Times Cited: 7
Adriana Celesia, Antonietta Notaro, Marzia Franzò, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1994-1994
Open Access | Times Cited: 7
Tricarboxylic Acid Cycle Relationships with Non-Metabolic Processes: A Short Story with DNA Repair and Its Consequences on Cancer Therapy Resistance
Enol Álvarez-González, L.M. Sierra
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 9054-9054
Open Access | Times Cited: 1
Enol Álvarez-González, L.M. Sierra
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 9054-9054
Open Access | Times Cited: 1
Single‐cell profiling guided combination therapy of c‐Fos and histone deacetylase inhibitors in diffuse large B‐cell lymphoma
Oliver H. Krämer, Günter Schneider
Clinical and Translational Medicine (2022) Vol. 12, Iss. 5
Open Access | Times Cited: 6
Oliver H. Krämer, Günter Schneider
Clinical and Translational Medicine (2022) Vol. 12, Iss. 5
Open Access | Times Cited: 6
Total synthesis and biological evaluation of histone deacetylase inhibitor WF-3161
Michael Kohr, Niklas Papenkordt, Manfred Jung, et al.
Organic & Biomolecular Chemistry (2023) Vol. 21, Iss. 21, pp. 4382-4387
Open Access | Times Cited: 3
Michael Kohr, Niklas Papenkordt, Manfred Jung, et al.
Organic & Biomolecular Chemistry (2023) Vol. 21, Iss. 21, pp. 4382-4387
Open Access | Times Cited: 3
Evaluation of the Therapeutic Potential of Histone Deacetylase 6 Inhibitors for Primary and Metastatic Uveal Melanoma
Husvinee Sundaramurthi, Zoltán Giricz, Breandán N. Kennedy
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9378-9378
Open Access | Times Cited: 4
Husvinee Sundaramurthi, Zoltán Giricz, Breandán N. Kennedy
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9378-9378
Open Access | Times Cited: 4
Novel hydroxamic acid derivative induces apoptosis and constrains autophagy in leukemic cells
Marten A. Fischer, Al‐Hassan M. Mustafa, Kristin Hausmann, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Marten A. Fischer, Al‐Hassan M. Mustafa, Kristin Hausmann, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Design, Synthesis, and Antiproliferative Activity of Selective Histone Deacetylases 6 Inhibitors Containing a Tetrahydropyridopyrimidine Scaffold
Bin Wang, Youcai Liu, Lejing Zhang, et al.
Molecules (2023) Vol. 28, Iss. 21, pp. 7323-7323
Open Access | Times Cited: 2
Bin Wang, Youcai Liu, Lejing Zhang, et al.
Molecules (2023) Vol. 28, Iss. 21, pp. 7323-7323
Open Access | Times Cited: 2
Can social adversity alter the epigenome, trigger oral disease, and affect future generations?
Sakr Khalid, Michaela Kearney, David McReynolds
Irish Journal of Medical Science (1971 -) (2024) Vol. 193, Iss. 5, pp. 2597-2606
Open Access
Sakr Khalid, Michaela Kearney, David McReynolds
Irish Journal of Medical Science (1971 -) (2024) Vol. 193, Iss. 5, pp. 2597-2606
Open Access
European Journal of Medicinal Chemistry Rationally Designed Febuxostat-Based Hydroxamic Acid and its pH-Responsive Nanoformulation Elicits Anti-Tumor Activity
Ritika Ritika, Zi-Yi Liao, Ping‐Yu Chen, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116866-116866
Closed Access
Ritika Ritika, Zi-Yi Liao, Ping‐Yu Chen, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116866-116866
Closed Access
Histone deacetylase inhibitors inhibit lung adenocarcinoma metastasis via HDAC2/YY1 mediated downregulation of Cdh1
Dongmei Wang, Yixiao Yang, Yuxiang Cao, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Dongmei Wang, Yixiao Yang, Yuxiang Cao, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Histone Deacetylase Inhibitors inhibit lung adenocarcinoma metastasis via HDAC2/YY1 mediated downregulation of Cdh1
Dongmei Wang, Yixiao Yang, Yuxiang Cao, et al.
Research Square (Research Square) (2023)
Open Access
Dongmei Wang, Yixiao Yang, Yuxiang Cao, et al.
Research Square (Research Square) (2023)
Open Access
Expression patterns and therapeutic implications of histone deacetylase-1 across carcinomas: a comprehensive molecular docking and MD simulation study
Bader Alshehri
Medical Oncology (2022) Vol. 39, Iss. 12
Closed Access
Bader Alshehri
Medical Oncology (2022) Vol. 39, Iss. 12
Closed Access